← Evidence map

ArticleCirculation2020

Letter by Qi et al Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".

Zhiyong Qi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020

2021

2022

this papercites it

Letter by Qi et al Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism". | Socratic